Title | Epigenetic Regulation by Sulforaphane: Opportunities for Breast and Prostate Cancer Chemoprevention. |
Publication Type | Journal Article |
Year of Publication | 2015 |
Authors | Atwell LL, Beaver LM, Shannon J, Williams DE, Dashwood RH, Ho E |
Journal | Curr Pharmacol Rep |
Volume | 1 |
Issue | 2 |
Pagination | 102-111 |
Date Published | 2015 Apr 01 |
ISSN | 2198-641X |
Abstract | Sulforaphane (SFN) is a phytochemical derived from cruciferous vegetables that has multiple molecular targets and anti-cancer properties. Researchers have demonstrated several chemopreventive benefits of SFN consumption, such as reductions in tumor growth, increases in cancer cell apoptosis, and disruption of signaling within tumor microenvironments both and . Emerging evidence indicates that SFN exerts several of its chemopreventive effects by altering epigenetic mechanisms. This review summarizes evidence of the impact of SFN on epigenetic events and how they relate to the chemopreventive effects of SFN observed in preclinical and clinical studies of breast and prostate cancers. Specific areas of focus include the role of SFN in the regulation of cell cycle, apoptosis, inflammation, antioxidant defense, and cancer cell signaling and their relationships to epigenetic mechanisms. Finally, remaining challenges and research needs for translating mechanistic work with SFN into human studies and clinical intervention trials are discussed. |
DOI | 10.1007/s40495-014-0002-x |
Alternate Journal | Curr Pharmacol Rep |
PubMed ID | 26042194 |
PubMed Central ID | PMC4450146 |
Grant List | P01 CA090890 / CA / NCI NIH HHS / United States R01 CA122906 / CA / NCI NIH HHS / United States R21 CA132236 / CA / NCI NIH HHS / United States |